Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
Hostname: page-component-ffbbcc459-l9rg9 Total loading time: 0.326 Render date: 2022-03-13T06:03:52.284Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }
  • English
The British Journal of Psychiatry The British Journal of Psychiatry

Article contents

Management of insomnia: treatments and mechanisms

Published online by Cambridge University Press:  02 January 2018

Sue Wilson  and
David Nutt
Sue Wilson*
Affiliation:
Psychopharmacology Unt, University of Bristol, Bristol, UK
David Nutt
Affiliation:
Psychopharmacology Unt, University of Bristol, Bristol, UK
*
Dr David Nutt, Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BSI 3NY, UK. Email: david.j.nutt@bristol.ac.uk
Rights & Permissions[Opens in a new window]

Summary

HTML view is not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Management of insomnia is an interesting subject at present. New drug treatments are now becoming available after a relatively static period since the development of the Z-drugs in the 1990s. Moreover, more evidence is coming to light about the length of drug treatment and the effectiveness of psychological therapies. This article briefly describes current treatments, both evidence-based and common practice, and goes on to describe some emerging approaches.

Type
Reappraisal
Information
The British Journal of Psychiatry , Volume 191 , Issue 3 , September 2007 , pp. 195 - 197
Copyright
Copyright © Royal College of Psychiatrists, 2007 

Footnotes

Declaration of interest

S.W. A. and D.N. have received funding from several pharmaceutical companies with an interest in the drug treatment of sleep disorder.

References

Allain, H., tue-Ferrer, D., Polard, E., et al (2005) Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs and Aging, 22, 749–765.CrossRefGoogle ScholarPubMed
Buscemi, N., Vandermeer, B., Hooton, N., et al (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. Journal of General Internal Medicine, 20, 1151–1158.CrossRefGoogle ScholarPubMed
Buscemi, N., Vandermeer, B., Hooton, N., et al (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 332, 385–393.CrossRefGoogle ScholarPubMed
Dundar, Y., Dodd, S., Strobl, J., et al (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology, 19, 305–322.CrossRefGoogle ScholarPubMed
Erman, M., Seiden, D., Zammit, G., et al (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Medicine, 7, 17–24.CrossRefGoogle ScholarPubMed
Espie, C. A., MacMahon, K. M., Kelly, H. L., et al (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep, 30, 574–584.CrossRefGoogle ScholarPubMed
Green, A., Hicks, J. A., Weeks, R., et al (2005) A cognitive-behavioural group intervention for people with chronic insomnia: an initial evaluation. British Journal of Occupational Therapy, 68, 518–522.CrossRefGoogle Scholar
Hicks, J. A., Argyropoulos, S. V., Rich, A. S., et al (2002) Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. British Journal of Psychiatry, 180, 528–535.CrossRefGoogle ScholarPubMed
Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., et al (2004) Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of Internal Medicine, 164, 1888–1896.CrossRefGoogle ScholarPubMed
Jansson, M. & Linton, S. J. (2005) Cognitive–behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. Journal of Occupational Rehabilitation, 15, 177–190.CrossRefGoogle ScholarPubMed
Kaynak, H., Kaynak, D., Gozukirmizi, E., et al (2004) The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Medicine, 5, 15–20.CrossRefGoogle ScholarPubMed
Krystal, A. D., Walsh, J. K., Laska, E., et al (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, doubleblind, placebo-controlled study in adults with chronic insomnia. Sleep, 26, 793–799.CrossRefGoogle Scholar
Morin, C. M. & Espie, C. A. (2003) Insomnia: A Clinician's Guide to Assessment and Treatment. Kluwer.CrossRefGoogle Scholar
Morin, C. M., Bootzin, R. R., Buysse, D. J., et al (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep, 29, 1398–1414.CrossRefGoogle Scholar
Nutt, D. J. (2005) NICE: The National Institute of Clinical Excellence – or Eccentricity? Reflections on the Z-drugs as hypnotics. Journal of Psychopharmacology, 19, 125–127.CrossRefGoogle ScholarPubMed
Roth, T., Walsh, J. K., Krystal, A., et al (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Medicine, 6, 487–495.CrossRefGoogle ScholarPubMed
Thase, M. E., Kupfer, D. J., Buysse, D. J., et al (1995) Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression. I. Comparison during acute depressive states. Biological Psychiatry, 38, 506–515.CrossRefGoogle ScholarPubMed
Winokur, A., DeMartinis, N. A. III, McNally, D. P., et al (2003) Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. Journal of Clinical Psychiatry, 64, 1224–1229.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.
You have Access
19
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Management of insomnia: treatments and mechanisms
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Management of insomnia: treatments and mechanisms
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Management of insomnia: treatments and mechanisms
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *